PI3K/PTEN/AKT/mTOR Pathway Genetic Variation Predicts Toxicity and Distant Progression in Lung Cancer Patients Receiving Platinum-based Chemotherapy

Non-small cell lung cancer (NSCLC) is still the leading cause of cancer-related deaths. The effect of the PI3K/PTEN/AKT/mTOR signaling pathway on cancer treatment, including NSCLC, has been well documented. In this study, we analyzed associations between genetic variations within this pathway and cl...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Pu, Xia, Hildebrandt, Michelle A.T., Lu, Charles, Lin, Jie, Stewart, David J., Ye, Yuanqing, Gu, Jian, Spitz, Margaret R., Wu, Xifeng
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2010
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2952281/
https://ncbi.nlm.nih.gov/pubmed/20447721
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lungcan.2010.04.008
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller